Product NDC: | 16590-625 |
Proprietary Name: | NEXIUM |
Non Proprietary Name: | ESOMEPRAZOLE MAGNESIUM |
Active Ingredient(s): | 20 mg/1 & nbsp; ESOMEPRAZOLE MAGNESIUM |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, DELAYED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 16590-625 |
Labeler Name: | STAT RX USA LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021153 |
Marketing Category: | NDA |
Start Marketing Date: | 20100819 |
Package NDC: | 16590-625-15 |
Package Description: | 15 CAPSULE, DELAYED RELEASE in 1 BOTTLE (16590-625-15) |
NDC Code | 16590-625-15 |
Proprietary Name | NEXIUM |
Package Description | 15 CAPSULE, DELAYED RELEASE in 1 BOTTLE (16590-625-15) |
Product NDC | 16590-625 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ESOMEPRAZOLE MAGNESIUM |
Dosage Form Name | CAPSULE, DELAYED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20100819 |
Marketing Category Name | NDA |
Labeler Name | STAT RX USA LLC |
Substance Name | ESOMEPRAZOLE MAGNESIUM |
Strength Number | 20 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA] |